Estradiol undecylate/norethisterone enanthate
From Wikipedia, the free encyclopedia
![]() | |
![]() Estradiol undecylate (top) and norethisterone enanthate (bottom) | |
Combination of | |
---|---|
Estradiol undecylate | Estrogen |
Norethisterone enanthate | Progestogen |
Clinical data | |
Other names | EU/NETE |
Routes of administration | Intramuscular injection |
Estradiol undecylate/norethisterone enanthate (EU/NETE) is a combination medication of estradiol undecylate (EU), an estrogen, and norethisterone enanthate (NETE), a progestin, which was developed by Schering for potential use as a combined injectable contraceptive in women but was ultimately never marketed.[1][2][3][4][5][6] It contained 5 to 10 mg EU and 50 to 70 mg NETE in oil solution and was intended for use by intramuscular injection at regular intervals.[1][2][3][4][5][6] Although never commercialized, EU/NETE was found to be effective and well tolerated.[1][2][3][4][5][6]
See also[]
- Polyestradiol phosphate/medroxyprogesterone acetate
- List of combined sex-hormonal preparations § Estrogens and progestogens
References[]
- ^ a b c Karim M, el-Mahgoub S (July 1971). "Conception control by cyclic injections of norethisterone enanthate and estradiol unducelate". Am. J. Obstet. Gynecol. 110 (5): 740–2. doi:10.1016/0002-9378(71)90268-7. PMID 5563241.
- ^ a b c Toppozada MK (1994). "Existing once-a-month combined injectable contraceptives". Contraception. 49 (4): 293–301. doi:10.1016/0010-7824(94)90029-9. PMID 8013216.
- ^ a b c Mokhtar K. Toppozada (1983). "Monthly Injectable Contraceptives". In Alfredo Goldsmith; Mokhtar Toppozada (eds.). Long-Acting Contraception. pp. 93–103. OCLC 35018604.
- ^ a b c Toppozada M (June 1977). "The clinical use of monthly injectable contraceptive preparations". Obstet Gynecol Surv. 32 (6): 335–47. doi:10.1097/00006254-197706000-00001. PMID 865726.
- ^ a b c Dr. S. S. Kadam (July 2007). Principles of Medicinal Chemistry Volume 2. Pragati Books Pvt. Ltd. pp. 381–. ISBN 978-81-85790-03-9.
- ^ a b c Newton JR, D'arcangues C, Hall PE (1994). "A review of "once-a-month" combined injectable contraceptives". J Obstet Gynaecol (Lahore). 4 Suppl 1: S1–34. doi:10.3109/01443619409027641. PMID 12290848.
Estrogens and antiestrogens | |||||||||
---|---|---|---|---|---|---|---|---|---|
Estrogens |
| ||||||||
Antiestrogens |
| ||||||||
|
Progestogens and antiprogestogens | |||||
---|---|---|---|---|---|
Progestogens (and progestins) |
| ||||
Antiprogestogens |
| ||||
|
Estrogen receptor modulators | |||||||
---|---|---|---|---|---|---|---|
ER |
| ||||||
GPER |
| ||||||
|
Progesterone receptor modulators | |||||||
---|---|---|---|---|---|---|---|
PR |
| ||||||
mPR (PAQR) |
| ||||||
|
![]() | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by . |
- v
- t
Retrieved from ""
Categories:
- Abandoned drugs
- Combined estrogen–progestogen formulations
- Combined injectable contraceptives
- Genito-urinary system drug stubs
Hidden categories:
- CS1: long volume value
- Infobox drug articles with non-default infobox title
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs that are a combination of chemicals
- All stub articles